Veracyte, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANAB
AnaptysBio, Inc. |
$15.85 | $640.07 M | -3.82 | 117 | $17.16 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$37.34 | $3.53 B | -11.86 | 290 | $4.01 M |
CYTK
Cytokinetics, Incorporated |
$45.74 | $6.05 B | -9.78 | 423 | $7.53 M |
ENTA
Enanta Pharmaceuticals, Inc. |
$5.25 | $273.43 M | -2.07 | 145 | $67.64 M |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GPCR
Structure Therapeutics Inc. |
$27.00 | $2.47 B | -23.59 | 136 | $0 |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
IDYA
IDEAYA Biosciences, Inc. |
$22.16 | $2.88 B | -19 | 124 | $23.39 M |
KROS
Keros Therapeutics, Inc. |
$10.84 | $1.76 B | -9.45 | 160 | $151,000 |
KURA
Kura Oncology, Inc. |
$7.26 | $1.66 B | -10.03 | 142 | $0 |
MGTX
MeiraGTx Holdings plc |
$6.28 | $306.74 M | -4.01 | 387 | $14.02 M |
MRUS
Merus N.V. |
$39.45 | $3.50 B | -19.38 | 172 | $43.95 M |
PTGX
Protagonist Therapeutics, Inc. |
$36.84 | $2.04 B | 13.7 | 126 | $60.00 M |
QURE
uniQure N.V. |
$14.04 | $258.77 M | -0.86 | 480 | $15.84 M |
RCKT
Rocket Pharmaceuticals, Inc. |
$10.30 | $2.06 B | -7.96 | 268 | $0 |
REPL
Replimune Group, Inc. |
$10.12 | $485.18 M | -2.44 | 331 | $0 |
RYTM
Rhythm Pharmaceuticals, Inc. |
$54.54 | $2.44 B | -8.63 | 226 | $77.43 M |
SLDB
Solid Biosciences Inc. |
$3.27 | $309.34 M | -2.05 | 88 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.08 | $1.66 B | -6.02 | 184 | $0 |
VRDN
Viridian Therapeutics, Inc. |
$18.12 | $776.72 M | -2.71 | 94 | $314,000 |
VTYX
Ventyx Biosciences, Inc. |
$2.02 | $229.83 M | -1.01 | 75 | $0 |